PhenixFIN Corporation 525 Notes due 2028 PFXNZ Q1 2026 Earnings Strong EPS Beat of 2541 Surprise
Dianthus Therapeutics Q1 2026 Earnings Narrower Loss Surprises as PreRevenue Biotech Advances Pipeline
Oxford Lane Capital Corp Q4 Fiscal 2025 Earnings EPS Misses Estimates Amid Challenging Market Conditions
MARA Q1 2026 Earnings EPS Misses Estimates Amid Challenging Quarter
CLIR Q1 2026 Earnings WiderThanExpected Loss Highlights PreRevenue Challenges
Sonoma Pharmaceuticals Inc SNOA Q1 2026 Earnings EPS Slightly Misses Estimates Amid Thin Revenue Disclosures